Oncternal Therapeutics, Inc. (ONCT)

Oncternal Therapeutics Market Cap

Oncternal Therapeutics has a market cap or net worth of $3.37 million as of November 21, 2024. Its market cap has decreased by -83.78% in one year.

• Market Cap: 3.37M
• Enterprise Value: -11.01M
• 1-Year Change: -83.78%
• Ranking: #5358
• Category: Nano-Cap
• Stock Price: $1.14

Market Cap Chart

Since February 3, 2004, Oncternal Therapeutics's market cap has decreased from $317.20M to $3.37M, a decrease of -98.94%. That is a compound annual growth rate of -19.61%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	3.40M	-89.24%
Dec 29, 2023	31.60M	-43.87%
Dec 30, 2022	56.30M	-49.82%
Dec 31, 2021	112.20M	2.47%
Dec 31, 2020	109.50M	80.10%
Dec 31, 2019	60.80M	223.40%
Dec 31, 2018	18.80M	-93.13%
Dec 29, 2017	273.80M	225.56%
Dec 30, 2016	84.10M	-14.45%
Dec 31, 2015	98.30M	77.12%
Dec 31, 2014	55.50M	-46.79%
Dec 31, 2013	104.30M	-60.46%
Dec 31, 2012	263.80M	25.02%
Dec 30, 2011	211.00M	56.99%
Dec 31, 2010	134.40M	-12.16%
Dec 31, 2009	153.00M	-75.02%
Dec 31, 2008	612.40M	22.21%
Dec 31, 2007	501.10M	-9.42%
Dec 29, 2006	553.20M	136.11%
Dec 30, 2005	234.30M	-29.56%
Dec 31, 2004	332.60M	4.85%
Feb 3, 2004	317.20M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Virpax Pharmaceuticals	3.23M
NuCana	3.19M
Oragenics	3.16M
Aptorum Group	3.14M
Palisade Bio	3.10M
Enveric Biosciences	3.08M
iSpecimen	3.07M
Quoin Pharmaceuticals	3.06M